July 17, 2014 / 8:40 AM / 5 years ago

Siemens to sell microbiology unit to U.S.-based Danaher

A Siemens logo is pictured on an office building of Siemens AG in Munich May 30, 2014. REUTERS/Lukas Barth

FRANKFURT (Reuters) - German engineering group Siemens agreed to sell its clinical microbiology business to Beckman Coulter [DHRBE.UL], a subsidiary of Danaher Corp, as part of a restructuring plan designed to improve profitability.

Siemens, which did not disclose financial details of the deal, said the move allowed it to focus its healthcare division more on its in-vitro business.

The transaction is expected to close in the first quarter of 2015 and is subject to regulatory approvals, Beckman Coulter said in a statement.

Reporting by Thomas Atkins; Editing by Prateek Chatterjee

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below